Literature DB >> 8640285

Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements.

E Clauser1, K M Curnow, E Davies, S Conchon, B Teutsch, B Vianello, C Monnot, P Corvol.   

Abstract

Two distinct types of cell-surface angiotensin II receptors (AT1 and AT2) have been defined pharmacologically and cDNAs encoding each type have been identified by expression cloning. These pharmacological studies showed the AT1 receptors to mediate all the known functions of angiotensin II in regulating salt and fluid homeostasis. Further complexity in the angiotensin II receptor system was revealed when homology cloning showed the existence of two AT1 subtypes in rodents and in situ hybridization and reverse transcription-polymerase chain reaction analyses showed their level of expression to be regulated differently in different tissues: AT1A is the principal receptor in the vessels, brain, kidney, lung, liver, adrenal gland and fetal pituitary, while AT1B predominates in the adult pituitary and is only expressed in specific regions of the adrenal gland (zona glomerulosa) and kidney (glomeruli). Expression of AT1A appears to be induced by angiotensin II in vascular smooth-muscle cells but is inhibited in the adrenal gland. Preliminary analysis of the AT1 promoters is also suggestive of a high degree of complexity in their regulation. Investigation of a potential role for altered AT1 receptor function has commenced at a genetic level in several diseases of the cardiovascular system. No mutations affecting the coding sequence have been identified in Conn adenoma and no linkage has been demonstrated with human hypertension by sib-pair analysis. None the less, certain polymorphisms that do not alter the protein structure have been found to be associated with hypertension and to occur at an increased frequency in conjunction with specific polymorphisms in the ACE gene in individuals at increased risk for myocardial infarction. Further characterization of the regions of the AT1 gene that regulate its expression are therefore needed. The physiological importance of the AT2 gene product still remains a matter of debate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640285     DOI: 10.1530/eje.0.1340403

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

1.  The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.

Authors:  X Wang; T J Murphy
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.

Authors:  S Tsuchida; T Matsusaka; X Chen; S Okubo; F Niimura; H Nishimura; A Fogo; H Utsunomiya; T Inagami; I Ichikawa
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 3.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

4.  Maternal caffeine administration leads to adverse effects on adult mice offspring.

Authors:  Diana F Serapiao-Moraes; Vanessa Souza-Mello; Marcia B Aguila; Carlos A Mandarim-de-Lacerda; Tatiane S Faria
Journal:  Eur J Nutr       Date:  2013-01-05       Impact factor: 5.614

5.  AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.

Authors:  Quaisar Ali; Tahir Hussain
Journal:  Hypertens Res       Date:  2012-02-02       Impact factor: 3.872

6.  Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM.

Authors:  A Doria; T Onuma; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

7.  AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

Authors:  Raphael Rozenfeld; Achla Gupta; Khatuna Gagnidze; Maribel P Lim; Ivone Gomes; Dinah Lee-Ramos; Natalia Nieto; Lakshmi A Devi
Journal:  EMBO J       Date:  2011-05-03       Impact factor: 11.598

Review 8.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

9.  Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids.

Authors:  Irina G Bogdarina; Peter J King; Adrian J L Clark
Journal:  J Mol Endocrinol       Date:  2009-05-01       Impact factor: 5.098

10.  Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil.

Authors:  Peter Hallersund; Herbert F Helander; Anna Casselbrant; Anders Edebo; Lars Fändriks; Anders Elfvin
Journal:  BMC Gastroenterol       Date:  2010-01-14       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.